
浏览全部资源
扫码关注微信
纸质出版日期:2013
移动端阅览
黄玲, 林慧, 吴琼诗, 等. 肾舒颗粒治疗慢性肾盂肾炎46例[J]. 中国实验方剂学杂志, 2013,19(17):309-312.
HUANG Ling, LIN Hui, WU Qiong-shi, et al. 46 Cases of Chronic Pyelonephritis Treatment of Shenshu Granules[J]. Chinese journal of experimental traditional medical formulae, 2013, 19(17): 309-312.
黄玲, 林慧, 吴琼诗, 等. 肾舒颗粒治疗慢性肾盂肾炎46例[J]. 中国实验方剂学杂志, 2013,19(17):309-312. DOI: 10.11653/syfj2013170309.
HUANG Ling, LIN Hui, WU Qiong-shi, et al. 46 Cases of Chronic Pyelonephritis Treatment of Shenshu Granules[J]. Chinese journal of experimental traditional medical formulae, 2013, 19(17): 309-312. DOI: 10.11653/syfj2013170309.
目的: 探讨肾舒颗粒治疗慢性肾盂肾炎(CPN)的临床疗效及作用机制。方法: 93例CPN患者按随机按数字法分为对照组47例和观察组46例。两组均采用西医常规序贯抑菌疗法
观察组在治疗的基础上加用肾舒颗粒
4 g/次
3次/d
开水冲服
若急性发作期改为8 g/次
3次/d。两组疗程均为12周。观察尿频、尿急、尿痛及腰痛等症状变化情况
检测尿液
进行清洁中段尿细菌定量培养
检测血清免疫球蛋白(IgA
IgG
IgM)及尿微量白蛋白(尿ALB)、尿β2-微球蛋白(尿β2-MG)、尿N-乙酰-β-氨基葡萄糖苷酶(尿NAG)
记录6个月随访期内急性发作例数及发作频次。结果: 观察组总有效率100%
优于对照组的85.1%(P<0.05);治疗后观察组血清IgA和IgG水平均上升且高于对照组(P<0.05);治疗后观察组尿频、尿急、尿痛及腰痛症状评分低于对照组(P<0.01);观察组尿ALB
β2-MG
NAG水平均低于对照组(P<0.01);观察组复发率、复发频次分别为32.6%和56.5%
均低于对照组的59.6%和102.1%(P<0.05
P<0.01)。结论: 肾舒颗粒治疗CPN临床疗效显著
并能减少CPN复发率。肾舒颗粒还能提高CPN免疫功能
改善肾小管功能
值得进一步研究。
Objective: To discuss the clinical efficacy and mechanism of Shenshu Granule in the treatment of chronic pyelonephritis (CPN). Method: Ninety-three patients with chronic pyelonephritis were randomly divided into observation group (n=47) and control group (n=46). Patients in the two groups were both treated with sequential therapy. Shenshu granule was used in the observation group (4 g per times
three times per day
if the acute attack
it was changed to 8 g per times). Symptoms of urinary frequency
urgency
dysuria and low back pain and other changes were observed
urine was tested and Clean Catch Midstream bacterial was cultured. IgA
IgG
IgM
urine Urina albumin
urine Urinary β2-m and Urine Urinary N-acetyl β-Glucosaminidas were tested. Number of cases of acute attack and attack frequency were recorded in the 6 months follow-up period. Result: The total efficacy of the observation group (100%) was significantly better than the control group (85.1%) (P <0.05). After treatment
serum IgA and IgG levels were raised and it was higher than the control group(P<0.05). The urinary frequency
urgency
dysuria and low back pain symptom scores of the observation group was lower than the control group after treatment(P<0.01). The urinary ALB 2-MG and NAG level in the observation group was lower than the control group(P<0.01). The recurrence rate and the frequency of recurrence in the observation group were 32.6% and 56.5%
lower than the control group(59.6% and 102.1%)(P<0.05
P<0.01). Conclusion: The Shenshu granule in treating of CPN have significant clinical effect and it can reduce the CPN recurrence rate
improve immune function
improve renal tubular function
it is worth to further research.
0
浏览量
4
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621